
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Raulo Frear, PharmD, general manager of OmedaRx, discusses methods to enhance management of drug utilization programs.
Raulo Frear, PharmD, general manager of OmedaRx, discusses methods to enhance management of drug utilization programs.